Abbott: Ventricular Dysfunction trials
The registry lists 12 Ventricular Dysfunction studies with Abbott as lead sponsor. 0 are open to participants now and 8 have results posted.
No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- HeartMate 3 CE Mark Study Long Term Follow-upCompletedNCT03022461Results posted
- MOMENTUM 3 Continued Access ProtocolCompletedNCT02892955Not applicableResults posted
- HeartMate 3 ELEVATE™ RegistryCompletedNCT02497950Results posted
- MOMENTUM 3 IDE Clinical Study ProtocolCompletedNCT02224755Not applicableResults posted
- HeartMate 3™ CE Mark Clinical Investigation PlanCompletedNCT02170363Not applicableResults posted
- Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac DesynchronizationCompletedNCT00187278Not applicableResults posted
- Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination TherapyCompletedNCT00121485Not applicableResults posted
- Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac TransplantationCompletedNCT00121472Not applicableResults posted
- HeartMate 3™ LIS StudyCompletedNCT02475460Not applicable
- Impact of Septal Vs Apical Pacing on Right and Left Ventricular PerformanceTerminatedNCT01798043Not applicable
- Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity TherapyCompletedNCT00187252Not applicable
- B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure PatientsCompletedNCT00187213Not applicable